(Q62801573)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17030018%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

title

B-cell immune responses in HIV positive and HIV negative patients with tuberculosis evaluated with an ELISA using a glycolipid antigen (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17030018%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

1 reference

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17030018%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

author name string

Nancy Simonney

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17030018%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

Pascal Chavanet

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17030018%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

Christian Perronne

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17030018%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

Marc Leportier

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17030018%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

Françoise Revol

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17030018%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

Philippe H Lagrange

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17030018%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

publication date

6 October 2006

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17030018%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17030018%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

volume

87

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17030018%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17030018%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

page(s)

109-122

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17030018%20AND%20SRC:MED&resulttype=core&format=json

Consensus statement. Global burden of tuberculosis: estimated incidence, prevalence, and mortality by country. WHO Global Surveillance and Monitoring Project

20 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2006.05.005

Evaluation of outpatients with suspected pulmonary tuberculosis in a high HIV prevalence setting in Ethiopia: clinical, diagnostic and epidemiological characteristics

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2006.05.005

Tuberculosis in patients with human immunodeficiency virus infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2006.05.005

The yield of acid-fast bacilli from serial smears in routine microscopy laboratories in rural Tanzania

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2006.05.005

Impact of human immunodeficiency virus infection on the epidemiology, clinical features, management, and control of tuberculosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2006.05.005

Clinical efficacy of the amplified Mycobacterium tuberculosis direct test for the diagnosis of pulmonary tuberculosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2006.05.005

Immunologic diagnosis of tuberculosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2006.05.005

Analysis of the immunological humoral response to Mycobacterium tuberculosis glycolipid antigens (DAT, PGLTb1) for diagnosis of tuberculosis in HIV-seropositive and -seronegative patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2006.05.005

Evaluation of different tests for the serodiagnosis of tuberculosis and the use of likelihood ratios in serology

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2006.05.005

Immunologic diagnosis of tuberculosis: a review

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2006.05.005

Reduced sensitivity of tuberculosis serodiagnosis in patients with AIDS in Uganda

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2006.05.005

Tuberculosis serodiagnosis in a predominantly HIV-infected population of hospitalized patients with cough, Botswana, 2002.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2006.05.005

Sero-diagnosis of tuberculosis with A60 antigen enzyme-linked immunosorbent assay: failure in HIV-infected individuals in Ghana.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2006.05.005

Evaluation of a novel 2,3-diacyl-trehalose-2'-sulphate (SL-IV) antigen for case finding and diagnosis of leprosy and tuberculosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2006.05.005

Antigenicity and specificity of selected glycolipid fractions from Mycobacterium tuberculosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2006.05.005

Preliminary evaluation of a Mycobacterium tuberculosis phenolglycolipid antigen in the serologic diagnosis of tuberculosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2006.05.005

Early abnormalities of the antibody response against Mycobacterium tuberculosis in human immunodeficiency virus infection.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2006.05.005

Serodiagnosis of tuberculosis. Evaluation of a sulpholipid antigen

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2006.05.005

Preliminary evaluation of a Mycobacterium tuberculosis lipooligosaccharide (LOS) antigen in the serological diagnosis of tuberculosis in HIV seropositive and seronegative patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2006.05.005

Comparison of A60 and three glycolipid antigens in an ELISA test for tuberculosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2006.05.005

Recognition of lipid antigens by T cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2006.05.005

Do CD1-restricted T cells contribute to antibody-mediated immunity against Mycobacterium tuberculosis?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2006.05.005

Antibody response to diphtheria, tetanus, and poliomyelitis vaccines in relation to the number of CD4+ T lymphocytes in adults infected with human immunodeficiency virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2006.05.005

Circulating immune complexes in human tuberculosis sera: demonstration of specific antibodies against Mycobacterium tuberculosis glycolipid (DAT, PGLTb1, LOS) antigens in isolated circulating immune complexes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2006.05.005

Effect of preventive treatment for tuberculosis in adults infected with HIV: systematic review of randomised placebo controlled trials

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2006.05.005

Rifampin and pyrazinamide vs isoniazid for prevention of tuberculosis in HIV-infected persons: an international randomized trial. Terry Beirn Community Programs for Clinical Research on AIDS, the Adult AIDS Clinical Trials Group, the Pan American He

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2006.05.005

Measuring the accuracy of diagnostic systems

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2006.05.005

Evaluation of a commercial immunodiagnostic kit incorporating lipoarabinomannan in the serodiagnosis of pulmonary tuberculosis in Ghana

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2006.05.005

Serological screening for tuberculosis in the community: an evaluation of the Mycodot procedure in an African population with high HIV-2 prevalence (Republic of Guinea-Bissau).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2006.05.005

Humoral response to Mycobacterium tuberculosis in patients with human immunodeficiency virus infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2006.05.005

Humoral response to Mycobacterium tuberculosis-specific antigens in African tuberculosis patients with high prevalence of human immunodeficiency virus infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2006.05.005

Prevalence of anti-mycolic acid antibodies in patients with pulmonary tuberculosis co-infected with HIV.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2006.05.005

The pattern of mycobacterial antigen recognition in sera from Mantoux-negative individuals is essentially unaffected by bacille Calmette-Guérin (BCG) vaccination in either south India or London

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2006.05.005

Evidence for human CD4+ T cells in the CD1-restricted repertoire: derivation of mycobacteria-reactive T cells from leprosy lesions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2006.05.005

T cell mediated immunity to Mycobacterium tuberculosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2006.05.005

Cytolytic T cells in the immune response to mycobacterium tuberculosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2006.05.005

Isolation of mycobacterium-reactive CD1-restricted T cells from patients with human immunodeficiency virus infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2006.05.005

Use of the 2,3-diacyl-trehalose and the purified protein derivative in the serodiagnosis of tuberculosis in AIDS.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2006.05.005

Surrogate marker of preclinical tuberculosis in human immunodeficiency virus infection: antibodies to an 88-kDa secreted antigen of Mycobacterium tuberculosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2006.05.005

Antigens of Mycobacterium tuberculosis recognized by antibodies during incipient, subclinical tuberculosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2006.05.005

Use of antibodies in lymphocyte secretions for detection of subclinical tuberculosis infection in asymptomatic contacts

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2006.05.005

Antibodies to mycobacteria in human tuberculosis. I. Development of antibodies before and after antimicrobial therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2006.05.005

Antibody levels to whole culture filtrate antigens and to purified P32 during treatment of smear-positive tuberculosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2006.05.005

Kinectics of circulating antibodies, immune complex and specific antibody-secreting cells in tuberculosis patients during 6 months of antimicrobial therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2006.05.005

Rapid diagnosis of active tuberculosis by detecting antibodies from lymphocyte secretions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2006.05.005

Anti-A60 immunoglobulin G in the serodiagnosis of tuberculosis in HIV-seropositive and seronegative patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2006.05.005

Infrequent detection of lipoarabinomannan antibodies in human immunodeficiency virus-associated mycobacterial disease. Swiss HIV Cohort Study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2006.05.005

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/J.TUBE.2006.05.005

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17030018%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

1 reference